Article Text
PDFCorrection
Correction: Amantadine toxicity causing visual hallucinations
Statistics from Altmetric.com
Barbara JM, Pace A. Amantadine toxicity causing visual hallucinations. Pract Neurol 2023;23:418-419. doi: 10.1136/pn-2023-003723.
Amantadine was incorrectly listed as an N-metyhl-d-aspartate (NMDA) receptor agonist twice in the text. Once in the abstract and once in the second paragraph of the discussion. The authors confirm it is an NMDA antagonist.
The online PDF and HTML have been updated.
Linked Articles
- A difficult case
Other content recommended for you
- Auditory hallucinations in Parkinson’s disease
- Successful treatment of intractable visual hallucinations with 5-HT2A antagonist ketanserin
- Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
- Drugs for Parkinson’s disease
- Visual hallucinations
- Visual hallucinations in Parkinson's disease: a review and phenomenological survey
- Feeling of presence in Parkinson's disease
- Deconstructing psychosis and misperception symptoms in Parkinson’s disease
- When a Parkinson’s disease patient starts to hallucinate
- Prospective study of hallucinations and delusions in Parkinson's disease